English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

This paper focuses on the production of docosahexaenoic acid (DHA; 22:6 n-3), a major ω3 polyunsaturated fatty acid (PUFA) with applications in foods and pharmaceuticals. Fish oils are currently the main source of PUFA including EPA and DHA. Growing interest in PUFA properties in various fields coupled with their significance in health and dietary requirements has encouraged searching for more suitable sources of these compounds, specially DHA. Some methods in lipid extracting process now allow to get a better industrial use for fish by-products. An important objective is to find cultivated microbiological sources that delivered DHA but no EPA. Potentialities of marine bacteria, microalgae and marine protists are described. The dinoflagellate Crypthecodinium cohnii seems the most efficient microrganism for the large-scale production of DHA devoid of EPA. The marine protists Thraustochytrids offer promising possibilities for DHA and other major PUFA production. C. cohnii as well as Thraustochytrium and Schizochytrium are able to produce large biomass and lipid amounts, and DHA at levels up to 60%. The first results in the production of n-3 long-chain PUFA in transgenic plants are given

Sources connues et potentielles de DHA pour les besoins de l’homme